Click HERE for Current News

June 30, 2003
• Beyond the Genome: The next goal of DNA research makes the breakthroughs of the past few years look like high school biology. Some even say it's impossible -- which is one reason Lee Hood is determined to go for it. - Business 2.0
• Syrrx Researchers Solve Atomic Structure of c-Kit Kinase, an Important Target of Gleevec
• Ciphergen Announces Diagnostic Biomarker Discovery Program with bioMerieux
• ActivX Awarded $1.1 Million Phase II SBIR/STTR Grant from National Cancer Institute for Establishing Drug Toxicity Profiles
• Frost & Sullivan Recognizes Fluidigm's Technology Innovation in Structural Proteomics
• Zyomyx Appoints Thomas J. McNaughton as Vice President, Intellectual Property
• Ciphergen Announces Opening of New Process Proteomics Center
• Biotech Is Back! - Great News on the Product Front and a Rebound in the Capital Markets Has Reignited Investor Enthusiasm ...
• Applied Molecular Evolution Enters Into Third Collaboration With Lilly for Optimization of Protein Therapeutics
• Millipore and AB Introduce New MALDIspot Kit: Expected to Accelerate MALDI MS Sample Preparation
• $65 Million for Applied Genomics and Proteomics Research Projects Aimed at Human Health
• Bio-Rad and Australian Proteome Analysis Facility Renew Strategic Collaboration
• Beyond Genomics to Chair Panel of Experts at BIO 2003: BG Leads Panel on the Application of Systems Biology in Drug Discovery
• Pure Protein L.L.C. Chief Scientist Chairing BIO2003 Cancer Session

June 9, 2003
• Caliper to acquire Zymark for $71 mln cash, stock
• Ciphergen Launches the First 'Matrix-Free' ProteinChip® Array At the ASMS: Revolutionary Advance in SELDI - TOF - Mass Spectrometry IDM
• Bruker Daltonics Displays New Products at ASMS, Introduces Numerous Advanced Methods and Applications for Life-Sciences Research
• Agilent Expands Mass Spectrometry Portfolio with New MS Instruments and Proteomics Software
• MDS Sciex Signs Distribution Agreement with SC BioSciences to Distribute NanoLC Proteomics System in Japanese Market
• Zyomyx Names Robert Monaghan New CEO: Company to Pursue Market-Driven Strategy for Protein Profiling Biochip System
• Bruker Daltonics Announces July 11, 2003 Investor & Analyst Open House
• Cytogen Raises $5 Million in Private Placement
• Biochips, Microarrays/Protein Arrays World Convention To Take Place July 14-15, Iselin, NJ
• IBM, Lynx and the Institute for Systems Biology Announce Study in Systems Biology
• AB Introduces New Linear Ion Trap Mass Spectrometer for Pharmaceutical and Proteomics Researchers at the ASMS Conference
• AB Introduces New 4700 Proteomics Discovery System at the ASMS Conference
• Ciphergen's ProteinChip® Technology Employed in Fight Against SARS
• MDS Sciex and Eksigent Technologies Announce Marketing Agreement
• GPC Bio says its key drug slows prostate cancer
• Eksigent Technologies Launches NanoLC Proteomics System
• Gyros Previews next Generation of Gyrolab Workstation for Protein Quantification at Nanoliter Scale
• FT/MS, The Proteomics Dream Machine
• Bruker and PNNL to Enhance Fourier Transform Mass Spec for Proteomics

June 2, 2003
• Ciphergen Announces Breakthrough in Protein Interaction Discovery and Assay Capabilities: Interaction Discovery Mapping™ Platform for SELDI ProteinChip® Systems Introduced
• Antibody test may diagnose madcow and treat it, too
• Myriad Proteomics Implements TimeLogic DeCypher to Accelerate Analysis of Human Proteome Data: DeCypher Improves Value of Proteomics Data and Extends Capability of Sun Microsystems Servers
• Data Demonstrate the Predictive Role of Bone Marker in Identifying Patients At High Risk of Cancer Related Bone Complications
• OGS: Seven Directors Resign Monday June 2, 11:33 am ET
• Agilent Licenses Protein Mass Tagging Technology from the Genomics Institute of the Novartis Research Foundation: Technology to Help Proteomics Researchers Identify New Drug Targets
• Georgetown Researchers Confirm Safety and Demonstrate First Evidence of Clinical Activity of Therion Biologics' TRICOM™ Vaccine in Advanced Cancers
• Chromos announces Q1 2003 financial results
• Ciphergen Announces Settlement of Lawsuit: Settlement Provides Ciphergen Undisputed, Exclusive Rights to Baylor Patents Related to SELDI Technology
• Proteome Systems and Iberica Announce Research Collaboration on Identifying Biomarkers for the Treatment of Osteoarthritis
• ProteoTech Receives Issuance of US Patent Pertaining To the Generation of Proteoglycan Transgenic Mice
• Gene-IT Provides Comparative Genomics Insight to Aventis with Anti-bacterial and Anti-fungal Projects
• GPC Biotech shares soar on cancer drug hopes
• GeneProt Licenses Its First Protein to Novartis
• GPC Biotech Appoints Dr. Prabhavathi Fernandes to Supervisory Board

May 21, 2003
• Roche, Maxygen In Interferon Pact
• Maxygen to Webcast Conference Call to Discuss New Alliance with Roche
• DNA, Protein, and Tissue/Cellular Arrays Market Expected to Reach Over $1.6 Billion by 2008
• Advanced Life Sciences to License Promising Technology from Argonne National Laboratory: Early Stage Proteomic Investigation to Focus on Prevention of Diseases Such As Alzheimer's, Type-2 Diabetes
• Merck KGaA Unit Biovation, Roche In Development Pact
• Baxter and GlycoFi to Collaborate on Development of New Platform For Manufacturing of Human Therapeutic Proteins
• LSBC Initiates Field Production of alpha-Galactosidase A
• 800 MHz NMR Helps St. Jude Researchers Determine Structures of Proteins Associated Childhood Diseases
• AstraZeneca: Esomeprazole is Effective in Suppressing Gastric Acid Secretion Compared to Other Proton Pump Inhibitors
• Proteomics Offers Various Opportunities to Improve Drug Development Process
• Cengent Therapeutics, A New Drug Discovery Company, Is Formed by the Merger of Structural Bioinformatics and GeneFormatics
• Genomics Fund, First and Only Mutual Fund to Concentrate in Genomics, Appoints Robert J. Sullivan Investment Manager
• Lynx Announces Its Financial Results for Q1 2003
• Lynx Announces Initiation of Gene Expression Analysis Collaboration with Millennium
• Leading Proteomics and Drug Discovery Companies to Present At Investment Forum
• Chromos announces ACE System deal with Cambridge Antibody Technology for the commercial manufacture of biologics
• Structure-Based Drug Design Conference to Take Place on June 23-24, 2003, In San Francisco, CA
• Lynx Announces Extension of Prostate Cancer Study With Institute for Systems Biology
• Virginia Bioinformatics Institute Installs World's Largest Academic Accelerated Bioinformatics System From TimeLogic
• For Protein Structure, Edwards Phones Friends

May 13, 2003
• Japan's National Cancer Center and Genedata Collaborate On Proteomics-Based Cancer Diagnostics
• Bruker AXS Announces Q1 2003 with Growing Revenues of $29.0 million
• Annual General Meeting of Shareholders in Biacore International AB
• Bruker Daltonics Reports Q1 2003 Product Revenue of $34.1 Million, an Increase of 19% Before Currency Effects
• Motley Fool: A Roche in the Biochips
• MorphoSys Posts Q1 Results for 2003
• Cognia and the Columbia Genome Center Collaborate to Create Novel Data Clustering Algorithms
• Caliper Selects Camstar's InSite to Manage Production of Its Lab-on-a-Chip Technology
• GPC Biotech Reports Strong Results for the Q1 2003
• Warburg Pincus invests $31 mln in Rib-X
• Cytogen Granted Summary Judgment of Non-Infringement for ProstaScint Patent
• Syrrx and RTS Announce Partnership To Sell High Throughput Structural Biology Automation Solutions
• BOTOX Cosmetic U.S. FDA Approval -- One Year Later
• Stressgen/Roche: For Development Of HspE7

April 28, 2003
• Bruker Daltonics To Webcast Q1 Conference Call on May 8, 2003
• Botox Smooths Allergan Quarter
• Elan Ezickson Joins GenPath Pharmaceuticals Management Team
• OGS Preliminary Unaudited Results 2002
• 4SC and ProQinase Collaborate on the Discovery of New Protein Kinase Inhibitors for Cancer Treatment
• Cognia Receives NSF Phase II SBIR Award for Molecular Trafficking and Localization Informatics Module
• LSBC to Initiate Field Production of Recombinant Aprotinin
• Thermo Electron Q1 profit falls
• Illumina Reports Financial Results for Q1 2003
• Ciphergen Announces Q1 2003 Earnings and Web Cast Conference Call
• Life Science Tools Companies: An Analysis
• Applied Biosystems Q3 Net 19 Cents/Share
• GTC Biotherapeutics Reports Q1 2003 Financial Results
• Celera Reports Q3 Fiscal 2003 Results
• Waters Q1 profit, stock rises
• LSBC Reports Improved Financial Results for Q1 2003

April 21, 2003
• LSBC to Release Q1 2003 Financial Results and Host Conference Call
• Celera Appoints Steven Ruben Vice President, Protein Therapeutics
• Oxford GlycoSciences: Three Directors Quit Board
• Myriad Out Of Gas
• Luminex Reports 2003 Q1 Results
• GTC Biotherapeutics to Release Q1 Financial Results and Host Webcast on Wednesday, April 23, 2003
• Celltech Offer For OGS Unconditional In All Respects
• ACLARA and the USC/Norris Comprehensive Cancer Center Launch Collaboration To Identify Cancer Biomarkers
• Thermo Electron To Hold Conference Call on Thursday, April 24, 2003
• Lynx Announces Publication of Manuscript by the National Cancer Institute And the Ludwig Institute for Cancer Research - Critically Evaluates Lynx's MPSS™ Technology With Other Expression Profiling Technologies
• Geron Receives U.S. Patent Covering Use of Telomerase Inhibitors in Patients
• LSBC Restructures Top Management
• Compugen Announces Discovery of Novel VEGF Protein
• Bruker Daltonics Reports Strong Q1 New Order Bookings
• PerkinElmer to Perform Proteomics Analysis in AlzheimerÕs Research Partnership
• Structural Genomix in Research Collaboration with Lilly

April 11, 2003
• Charles River Laboratories and Proteome Systems Launch Proteomic Services
• RPI and Elan Conclude Ribozyme-Based Oncology Joint Venture
• Under Contract, Bio Curex Begins Producing the RECAF Protein
• Ciphergen Adds Clinical Diagnostics Executive to Board of Directors
• Vivascience Extends Its Product Line for Protein Purification
• Bio-Rad to Report 1st Financial Results on Tuesday, April 29, 2003
• DRAXIMAGE and Cytogen Agree to End BrachySeed Agreements
• Enzyme hCE1 Could Offer Treatment for Cocaine and Heroin Overdose and Exposure to Chemical Warfare Agents
• Canada's Structural Genomics Consortium Wins $95M Proteomics Grant
• GeneProt Slashes Staff in Half; Will Refocus Customer Base
• Bruker Daltonics to Merge with Bruker AXS
• Biacore Annual General Meeting of Shareholders May 8, 2003
• OGS Board Recommends Celltech Offer
• OGS Update on Merger Discussions
• Protein Pathways Announces Research Collaboration with Merck

March 30, 2003
• SYN X's Agreement with VWR to Deliver Significant Sales Revenue
• SYN-X Announces Profitable Q4 and Results 2002
• OGS Announces Progress in Medarex Alliance
• OGS Submits Amendment to the New Drug Application for Zavesca® (miglustat) to the FDA
• Beyond Genomics Appoints Robert N. McBurney, PhD, Senior VP, Research & Development and CSO, and Paul Stroobant, PhD, VP, Biochemistry & Protein Discovery
• Ciro International Announces Agreement With Advanced Bio/Chem
• Bio-IT World Expo Announce 'Best of Show' Award Winners, including AnVil's proteomics data management system
• Nature Biotechnology: Challenges in proteomics; volume 21 Number 3
• ActivX Reports Key Advances on the Large-Scale Profiling of Kinases and Other Nucleotide Binding Proteins
• Boston Life Sciences' Collaborating Scientists Identify Role of Inflammatory Protein in Promoting Optic Nerve Regeneration
• Bruker AXS Buys Majority of Baltic Scientific Instruments, Creates JV
• Prolinx Closes Shop, Auctions Assets
• Micromass Sells Inorganic Mass Spec Business to New British Start-Up
• Proteome Sciences has developed Sensitizer, a unique method of enhancing the sensitivity 100 fold of mass spectrometers for the identification of biomarkers

March 24, 2003
• NIH installs MASCOT® Protein Identification Software on Central Server
• Bruker AXS Enters Technology Joint Venture for Solid State X-Ray Detector Technology
• Cellzome Hits Target on Series C Financing
• Pure Protein Appoints Pierre Chretien to Spearhead Its Canadian Initiative
• Prolinx Closes Shop, Auctions Assets
• CAT To Pursue OGS Merger Despite Celltech Share Purchase

March 17, 2003
• Court upholds ruling in Applied Biosystems/MDS Sciex patent suit against Micromass
• Bruker Daltonics Introduces Esquire HCT with UltraScan, a Novel High Capacity Trap for Faster, Even More Sensitive Bioanalysis
• Bruker Daltonics Introduces Novel Q-q-FTMS System with New 9.4 and 12 Tesla Magnets for Proteomics by Ultra-High Resolution Mass Spectrometry
• New Technology Launched for Accelerated Functional Proteomics Research; Automated SPR-MS Functionality Empowers Biacore 3000
• Agilent Technologies Introduces Breakthrough Ion Trap Mass Spectrometer for Proteomics and Trace Compound Analysis
• BD Names Vincent A. Forlenza President of BD Biosciences
• EraGen Announces Patent Licensing Agreement with Therascope AG for Drug Discovery Applications
• Advion BioSciences and Thermo Electron to Co-Market Automated Nanoelectrospray System to Life Science Market
• Gyros and Kratos Analytical Mass Spectrometry Collaboration a Success
• MDS Lab Services Teams with UVic to Expand Proteomics Center in British Columbia
• PerkinElmer, Genomic Solutions in Proteomics Distribution Pact
• Montana Prof. Goes on Proteomics Tour
• Genomics and Proteomics Find Home in BioDefense
• SGI Technologies Enable First-Place Win in Protein-Folding Competition: University of Waterloo's School of Computer Science's RAPTOR Program Ranked First in Biennial Protein-Structure-Prediction Competition
• Amersham Biosciences Launches Protein Purification System To Link Process Development and Large Scale Production

March 9, 2003
• GlaxoSmithKline to Evaluate Ambit ProteomeScan™ Technology for Small Molecule Profiling
• SYN X Pharma Achieves First Milestone, Receives Payment from Alzheimer's Disease Licensing Agreement
• Zyomyx Sells Protein Profiling Biochip System to Aventis
• SomaLogic Raises $19.5 Million in Private Equity Financing
• Protein, AIB1, May Explain Tamoxifen Resistance
• Matritech's NMP22 BladderChek Found Approvable By The FDA
• Protein, Neuroglobin, Could Shield Brain During Stroke
• Bruker Daltonics to Introduce Significant New Products at Pittcon 2003
• SurroMed Announces BioMarker Discovery Agreement With InterMune: SurroMed to Undertake Proteomic and Metabolite Profiling Analysis Of InterMune's Clinical Samples
• Microarray Technologies & Protein Array World Congress To Take Place June 23-25, Iselin, NJ
• Syrrx Successfully Enforces Submicroliter Crystallization Patent
• Biosite Receives FDA Clearance for New Chest Pain Screen
• Matritech and Mitsubishi Kagaku Medical Finalize Agreement to Develop NMP66 Blood Test for Breast Cancer
• Genetix Announces Preliminary Financial Results For 2002
• Frost & Sullivan Report: Integrated and Customized Solutions to Drive Proteomics Sample Preparations
• GeneProt announces CEO Appointment
• De Novo Pharmaceuticals and Roche announce the successful creation of a Comprehensive Platform for de novo Drug Design

February 28, 2003
• Proteomics Market Estimated to Reach $2.68B by 2008: The Demand for Drug Discovery Is Pushing Proteomics Technology Vendors To Develop Innovative Platforms
• Advancing High-Throughput Proteomics with FTMS: Bruker Daltonics Announces Collaboration to Develop Highly Sensitive Protein Analysis Methods with Ultra-high Field FTMS
• LSBC and U of Arkansas Announce NIDA/NIH-Funded Collaboration to Develop Therapeutic Antibody Treatment for Drug Abuse Victims
• Bruker AXS Reports Record Revenues of $104.3 Million in 2002
• Panacea Announces Opening of New Facility And Launch of New Website
• Linux Networx Asia and DigiGenomics Penetrate Biotech Market
• Stressgen granted U.S. patent covering HspE7 and additional human papillomavirus therapeutic products
• Abnormal form of a protein, PNL, is fundamental cause of congestive heart failure
• Protein Marker, transthyretin monomer (TTR), of Blood-Brain Barrier Disruption Discovered
• SkyePharma Announces Proof of Principle for Second Sustained-Release Injectable Technology for Protein Drugs
• Lynx Revenues Down, Net Loss Up
• Xerion Acquires Rights to Tufts Cancer Targets

Special Presentation: INTELLECTUAL PROPERTY PROBLEMS AND STRATEGIES FOR PROTEOMICS TECHNOLOGY by Darby & Darby PC

February 23, 2003
• Bruker Daltonics Reports 2002 Product Revenue of $116.2 Million, an Increase of 21.6%
• ActivX Promotes David A. Campbell, Ph.D., to New Position to Lead Medicinal Chemistry Programs
• Biacore: Year-End Report 2002
• Biochips World Summit & Exposition to Take Place June 23-25, Iselin, NJ
• Biosite Announces Collaboration Agreement With Neurocrine Biosciences
• SomaLogic Raises $19.5 Million in Private Equity Financing
• Knowledge Management Lagging in Drug Discovery R&D, Opportunities for Significant Productivity and Time Improvements
• Protein-like structures associated with Creutzfeldt-Jakob disease
• Brain Protein, WAVE-1, Linked to Mental Retardation
• Incyte Reports 2002 Financial Results, Provides Outlook for 2003

February 18, 2003
• Charles D. Nash Resigns as Director of LSBC
• Ciphergen Reports Record Financial Results for the Q4 And Fiscal Year 2002: Revenue Increased 86% in Q4 and 106% for the Year
• Accelrys To Provide Technology For Functional Annotation of Confirmant's Protein Atlas of the Human Genome™
• Ciphergen and Biosite Announce Collaboration: Principal Goal is Improved Diagnostics Based on Protein Biomarkers
• Discovery Partners International Reports Fourth Quarter 2002 Results With Record Revenues
• As Little Bear Ups the Ante, Caliper Plays Hard to Get
• Mass Spec for DNA Analysis? ABRFers Hear from the Experts
• Microarray Market Could Top $5 Billion by 2010, Study Says
• Gryphon Therapeutics Announces Synthetic Erythropoietin Protein Details Published in Science
• CURIS' BMP-7 Protein Drug Candidate Reported to Enhance Stroke Recovery
• PAI-1 Protein Blocks Obesity in Mice
• Genitope Unlocks Structure of HER2 Protein Receptor
• Study Shows Tumors Don't Grow Without IL-1 Protein
• CURIS' Proprietary Hedgehog Protein Restores Nerve Function In Models of Diabetes-Induced Nerve Damage
• Tim Sutton Appointed as CFO for NextGen Sciences

Friday February 7, 2003
• Amersham Biosciences and Thermo Electron to Provide Mass Spectrometry-based Solutions to the Proteomics Research Community
• Miraculins Announces Collaboration With Proteomics Research Group
• PerkinElmer and MDS Sciex Announce Development of Next-Generation MALDI-TOF Mass Spectrometer for Proteomics Market
• Protedyne's BioCube System Passes Acceptance at Molecular Staging: Automation Earmarked to Accelerate Protein BioChip Processing Service
• Matritech Reports Q4 and 2002 Year End Financial Results
• Protedyne and TekCel Team Up to Offer Integrated High-Capacity Compound Storage and High Throughput Laboratory Automation Systems for Drug Discovery
• MelTec Collaborates with Proteome Center Rostock in Rheumatoid Arthritis
• ProMetic and American Red Cross Form Strategic Alliance to Develop an Improved Plasma Protein Purification Process
• Illumina Launches Human Genome RefSet Oligos for Spotted Gene Expression Microarrays
• Proteus Granted Patent Covering Its Phenomics Discovery Technology
• Zyomyx Launches New Protein Profiling Biochip System and First Human Cytokine Biochip
• Sun Microsystems Powers Bind Web Services at the Blueprint Initiative: Sun Wins Multi-Million Dollar Bioinformatics Database Deal
• Agilent Forms Advisory Board for Life Sciences
• Incyte Expands Proteome BioKnowledge Library with Information Linking Human Protein Function to Disease: New Offering Helps Research Scientists Prioritize Drug Targets
• Bruker Daltonics to Webcast Q4 Conference Call on February 20, 2003
• Proteome Systems Releases New Generation of Intelligent Electrophoresis Solutions
• Tecan US Launches Te-MO 3/3 Multi-Channel Pipetting System, at Lab Automation 2003
• System Can Detect 'Mad Cow'-Linked Prions in Blood
• A naturally-occurring protein appears to protect brain cells after a stroke, according to a new study in mice
• RedStorm Licenses Protein Structure Software to UCSD
• Amersham, Thermo Pen Sales and Marketing Partnership in Proteomics
• GPC Biotech Licenses IP from Ariad

Friday January 31, 2003
• Agilent Technologies and DiagnoSwiss to Develop New Technology for High-Performance Proteomics Analysis
• GPC Biotech Introduces New Drug Discovery Technology, LeadCode™
• GPC Biotech Announces Collaboration with Eli Lilly and Company Involving New Drug Discovery Technology
• Incyte to Report Q4 2002 Financial Results on February 19, 2003
• LION bioscience Launches LION DiscoveryCenter for Faster Drug Discovery
• ZymoGenetics to Webcast Presentation at Merrill Lynch Conference
• Evotec OAI's Preliminary Results 2002: Q4 Results Exceeding Expectations
• Joint study at Dana-Farber Cancer Institute, Oregon Health and Science University and Brigham and WomenÕs Hospital on protein-cancer connection underscores promise of targeted therapies

Wednesday January 29, 2003
• Molecular Staging Enters Into Proteomics Collaboration with Lilly In Sepsis
• LSBC Reports Financial Results for the Q4 and Full Year 2002
• Investments of $1 Million for Dynapix Intelligence Imaging
• Protiveris Completes Prototype VeriScan™ 3000
• AB Announces Enhancements to the Celera Discovery System and New Academic Subscription Model
• Ciphergen Announces Expanded Collaboration With Pfizer: Ciphergen's Copenhagen Biomarker Discovery Center to Support Pulmonary Study
• Biosite Reports Q4 2002 Revenue and EPS Growth: Company Exceeds $100 million in Product Sales
• SYN X Pharma's Tests for Traumatic Brain Injury Receive Health Canada Approval
• Beckman Coulter Announces New Systems Specifically Designed for Protein Discovery: New Product Introductions Launch Company's ProteomeLab Initiative
• MDS Sciex announces ProteoSpin™
• Doctors Urged to Check for Key Heart Marker
• Keck Gives $1.25 Million to UC Riverside to Equip New Plant Proteomics Lab
• Inpharmatica, Serono Expand Proteomics Deal
• LSBC, Novozymes Biotech Collaborate on Gene Improvement Research

Friday January 24, 2003
• Proteomics and Protein Microarrays Event to Show Usefulness of Emerged Technologies!
• MelTec Forms Alliance with Fraunhofer Institute FIT; Next-Generation IT Platform for Topological Proteomics to be Created
• GeneData and Novartis Expand Collaboration Agreement in Lead Discovery
• Cellzome Licenses Technology from LION bioscience
• PanTherix Enters Agreement with Genome Therapeutics to Determine Essential Structural Information for Anti-Infective Targets and Leads
• Cambridge Antibody Technology and OGS Merge
• MorphoSys and Lonza Biologics Sign Antibody Manufacturing Agreement
• Lynx Announces 25% Workforce Reduction
• AxCell Establishes Research Collaboration With Celgene
• Diagnostic Products Corporation Gets License to Compugen Prostate Proteins
• Former Celera proteomics chief Scott Patterson joins Farmal Biomedicines as CSO
• PNNL, MIT Build Library of One Billion Antibodies

Friday January 17, 2003
• MRG Report Shows How Proteomics Will Improve Pharmaceutical Industry Profits: Projects $3.3 Billion Proteomics Market Will Shorten Development Time for New Drugs
• OGS to Receive Patent for Proteomics Research Processes
• MDS Proteomics and Eli Lilly Canada announce new collaborative research initiative in proteomics
• U of Pennsylvania Licenses Confirmant's The Protein Atlas of the Human Genome™ Proteomics Database
• Bolder BioTechnology Awarded Grant From The National Cancer Institute To Develop Therapeutic Proteins for Treating Thrombocytopenia
• Biovitrum AB Signs an Agreement with Lundbeck to Produce Protein Therapeutics
• Protein Nabbed as Cancer Ally
• The Michael J. Fox Foundation for Parkinson's Research Awards Over $2.6 Million to Study Role of Protein Degradation in Parkinson's
• Lynx Receives Additional Delisting Notice from Nasdaq, Initiates Stock Split
• ABBOTT AND LUMINEX ENTER INTO AGREEMENTS FOR IN VITRO DIAGNOSTIC TECHNOLOGY AND PRODUCTS
• Systems Biology at MIT: It's All Over the Place
• Eurogentec acquires WITA Proteomics

Friday January 10, 2003
• Lynx Expands, Accelerates Takara Agreement
• Bruker Daltonics, Genomic Solutions Ink Reseller Agreement
• Biological clock is two-faced protein, scientists say - CNN.com
• Structural Bioinformatics, GeneFormatics to probe proteomics together
• Cephalon and MDS Proteomics Announce Research Collaboration
• Protea Biosciences Announces Agreement to Provide Proteomics Services to a Major Pharmaceutical Company
• Amersham and GeneBio Enter Into a Bioinformatics and Proteomics Collaboration
• OGS Signs Proteomics Contract with Pfizer
• GPC Biotech Announces Achievement of Two Milestones in Drug Discovery Alliance With ALTANA
• Institute for Systems Biology Awarded $12 Million to Study Innate Immunity
• AB And Celera Q2 FY 2003 Financial Results And Conference Call Scheduled For January 23, 2003
• ActivX and Sosei to Collaborate on Drug Re-profiling Program
• HTS Biosystems Presented New Research on Next-Generation SPR Technology for Growing Proteomics Market
• Protein that plays a key role in the eye pupil's response to light

Sunday January 5, 2003
• Venture Capital for Genomics Sinks Amid Upswing in Overall Biotech Funding in 2002
• Bruker Daltonics Reports Strong Q4 Life-Science Order Flow
• Biotech Firms Stagger Into the 21st Annual J.P. Morgan H&Q Healthcare Conference
• Cambridge Antibody, Dyax Expand Licensing Pact
• U.S. venture capital records dismal 2002
• Applied Molecular Evolution Advances Optimized Versions of anti-TNF alpha and anti-CD20 Monoclonal Antibody Therapeutic Candidates

Copyright © 2010 ProteinScience.com. All rights reserved.
ProteinScience.com is not affiliated with Protein Sciences, Inc. or the journal Protein Science.